Dyadic Announces Continued Progress Towards Commercialization of Animal-Free Recombinant Serum Albumin
07. August 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Worldwide Human Albumin Industry to 2026 - by Manufacturers, Regions, Technology and Product Type
30. August 2021 05:18 ET
|
Research and Markets
Dublin, Aug. 30, 2021 (GLOBE NEWSWIRE) -- The "Human Albumin Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Product Type" report has been added to...
China Blood Products Market Report 2020-2027: Policy, Status Quo, Market Structure, Supply & Demand, Market Size, Competitive Pattern
19. April 2021 07:08 ET
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "China Blood Product Industry Report, 2020-2027" report has been added to ResearchAndMarkets.com's offering. With the adjustment in the catalog of...